1. Beltz RE ,Jolley WB, Waters RN, Hinshaw DB (1972) Growth inhibitors rapidly inactivated by the host as potential antineoplastic agents in intra-arterial infusion chemotherapy. Oncology 26:121–133
2. Bloch A, Dutschman G, Grindey G, Simpson CL (1974) Prevention by testosterone of the intestinal toxicity caused by the antitumor agent 3-deazauridine. Cancer Res 34:1299–1303
3. Brockman RW, Pittillo RF, Shaddix S, Hill DL (1970) Mode of action of azotomycin. Antimicrob Agents Chemother 1969:56–62
4. Cain BF, Atwell GJ (1974) The experimental antitumor properties of three congeners of the acridylmethanesulphonanilide (AMSA) series. Eur J Cancer 10:539–549
5. Catane R, Ovejera AA, Houchens DP, von Hoff DD, Davis HL jr, Wolpert MK, Rozencweig M, Muggia FM (1978) Rationale for further clinical trials with 6-diazo-5-oxo-L-norleucine (DON). Proc Am Assoc Cancer Res Proc Am Soc Clin Oncol 19:317